IC 16-42-26-2 — "Investigational drug, biological product, or device"
Chapter 26. Drugs: Investigational Drug, Biological Product, or Device
Section text
Sec. 2. As used in this chapter, "investigational drug, biological product, or device" means an investigational or experimental: (1) drug; (2) biological product; or (3) medical device; that has successfully completed Phase I of a federal Food and Drug Administration approved clinical trial, but has not been approved for general use by the federal Food and Drug Administration and remains under investigation in a clinical trial.
As added by P.L.2-2015, SEC.3.
Source: official publisher (2026 edition)